Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Lexicon Pharmaceuticals Inc shares valued at $94,797 were purchased by COATS LONNEL on Nov 16 ’23. At $1.05 per share, COATS LONNEL acquired 90,000 shares. The insider’s holdings grew to 914,359 shares worth approximately $1.85 million following the completion of this transaction.
Also, COATS LONNEL purchased 10,000 shares, netting a total of over 10,100 in proceeds. Following the buying of shares at $1.01 each, the insider now holds 824,359 shares.
Before that, DEBBANE RAYMOND had added 148,820 shares to its account. In a trade valued at $153,805, the Director bought Lexicon Pharmaceuticals Inc shares for $1.03 each. Upon closing the transaction, the insider’s holdings increased to 148,820 shares, worth approximately $2.71 million.
As published in their initiating research note from Jefferies on March 07, 2023, Lexicon Pharmaceuticals Inc [LXRX] has been a Hold and the price target has been revised to $3. Analysts at Piper Sandler started covering the stock with ‘”an Overweight”‘ outlook in a report released in mid August. As of January 29, 2021, JP Morgan has increased its “an Underweight” rating to a “Neutral” for LXRX. Earlier on January 29, 2021, Wedbush downgraded its rating. Their new recommendation was “a Neutral” for LXRX stock which previously was a “an Outperform”.
Analyzing LXRX Stock Performance
During the last five days, there has been a drop of approximately -0.98%. Over the course of the year, Lexicon Pharmaceuticals Inc shares have jumped approximately 32.03%. Shares of the company reached a 52-week high of $3.73 on 02/16/24 and a 52-week low of $1.24 on 01/19/24. A 50-day SMA is recorded $2.38, while a 200-day SMA reached $1.72. Nevertheless, trading volume fell to 2.6 million shares from 1.33 million shares the previous day.
Support And Resistance Levels for Lexicon Pharmaceuticals Inc (LXRX)
According to the 24-hour chart, there is a support level at 1.98, which, if violated, would cause prices to drop to 1.94. In the upper region, resistance lies at 2.05. The next price resistance is at 2.08. RSI (Relative Strength Index) is 42.28 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.10, which suggests the price will decrease in the coming days. Percent R is at 90.48%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Is Lexicon Pharmaceuticals Inc subject to short interest?
Stocks of Lexicon Pharmaceuticals Inc saw a sharp rise in short interest on Mar 28, 2024 jumping by 0.84 million shares to 21.91 million. Data from Yahoo Finance shows that the short interest on Feb 29, 2024 was 21.07 million shares. A jump of 3.83% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 4.26 of the overall float, the days-to-cover ratio (short ratio) jumped to 4.26.
